{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:39:49Z","timestamp":1785296389360,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ajo.2012.09.025","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T11:24:28Z","timestamp":1354620268000},"page":"418-428.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Impact of the Revised American Academy of Ophthalmology Guidelines Regarding Hydroxychloroquine Screening on Actual Practice"],"prefix":"10.1016","volume":"155","author":[{"given":"David J.","family":"Browning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2012.09.025_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2012.09.025_bib2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2012.09.025_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archopht.122.7.973","article-title":"Multifocal electroretinographic evaluation of long-term hydroxychloroquine users","volume":"122","author":"Maturi","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2012.09.025_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-005-7349-6","article-title":"Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates","volume":"110","author":"Tzekov","year":"2005","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2012.09.025_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00417-011-1753-2","article-title":"Comparison of different screening methods for chloroquine\/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography","volume":"250","author":"Missner","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2012.09.025_bib6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0002-9394(02)01800-7","article-title":"Reply to defining ideal body weight","volume":"134","author":"Browning","year":"2002","journal-title":"Am J Ophthamol"},{"issue":"4","key":"10.1016\/j.ajo.2012.09.025_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archophthalmol.2011.371","article-title":"Comparison of screening procedures in hydroxychloroquine toxicity","volume":"130","author":"Marmor","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2012.09.025_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9394(02)01392-2","article-title":"Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity","volume":"133","author":"Browning","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"1A","key":"10.1016\/j.ajo.2012.09.025_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(83)91267-6","article-title":"Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy","volume":"75","author":"Bernstein","year":"1983","journal-title":"Am J Med"},{"issue":"1A","key":"10.1016\/j.ajo.2012.09.025_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(83)91269-X","article-title":"Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials","volume":"75","author":"Mackenzie","year":"1983","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.ajo.2012.09.025_bib11","first-page":"292","article-title":"Ocular safety of hydroxychloroquine","volume":"23","author":"Bernstein","year":"1991","journal-title":"Ann Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2012.09.025_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9394(87)90005-5","article-title":"Hydroxychloroquine therapy in massive total doses without retinal toxicity","volume":"104","author":"Johnson","year":"1987","journal-title":"Am J Ophthalmol"},{"issue":"2 Suppl 1","key":"10.1016\/j.ajo.2012.09.025_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0049-0172(10)80009-5","article-title":"The ocular safety of hydroxychloroquine","volume":"23","author":"Easterbrook","year":"1993","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ajo.2012.09.025_bib14","first-page":"385","article-title":"Hydroxychloroquine toxicity despite normal dose therapy","volume":"25","author":"Falcone","year":"1993","journal-title":"Ann Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2012.09.025_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9394(14)76853-9","article-title":"Hydroxychloroquine retinopathy","volume":"112","author":"Weiner","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2012.09.025_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/OPTH.S27731","article-title":"Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiological study","volume":"6","author":"Farrell","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2012.09.025_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2004.050120","article-title":"Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy","volume":"89","author":"Almony","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2012.09.025_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.iae.0000226540.61840.d7","article-title":"Optical coherence tomography findings in hydroxychloroquine and chloroquine-associated maculopathy","volume":"1","author":"Fung","year":"2007","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"10.1016\/j.ajo.2012.09.025_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.iae.0000236205.28853.76","article-title":"Optical coherence tomography in hydroxychloroquine retinopathy: two observational case reports","volume":"1","author":"Fontaine","year":"2007","journal-title":"Retin Cases Brief Rep"},{"issue":"5","key":"10.1016\/j.ajo.2012.09.025_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ajo.2006.12.042","article-title":"Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography","volume":"143","author":"Lyons","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2012.09.025_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2147\/OPTH.S14257","article-title":"Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the \u201cflying saucer\u201d sign)","volume":"4","author":"Chen","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2012.09.025_bib22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bjo.2008.157198","article-title":"Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence","volume":"93","author":"Kellner","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"13","key":"10.1016\/j.ajo.2012.09.025_bib23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","article-title":"If nothing goes wrong, is everything alright? Interpreting zero numerators","volume":"249","author":"Hanley","year":"1983","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ajo.2012.09.025_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.83.10.1194h","article-title":"Retinopathy after long term, standard doses of hydroxychloroquine","volume":"83","author":"Thorne","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2012.09.025_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archophthalmol.2010.321","article-title":"Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy","volume":"129","author":"Michaelides","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"Pt 6","key":"10.1016\/j.ajo.2012.09.025_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/eye.1998.236","article-title":"Royal College of Ophthalmologists guidelines: ocular toxicity and hydroxychloroquine","volume":"12","author":"Fielder","year":"1998","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.ajo.2012.09.025_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bjophthalmol-2011-300504","article-title":"Quantitative assessment of the 103 hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity","volume":"96","author":"Adam","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2012.09.025_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/B:DOOP.0000018385.99215.0d","article-title":"Assessing hydroxychloroquine toxicity by the multifocal ERG","volume":"108","author":"Moschos","year":"2004","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2012.09.025_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.eye.6701818","article-title":"Abnormalities on the multifocal electroretinogram may precede clinical signs of hydroxychloroquine retinotoxicity","volume":"20","author":"Teoh","year":"2006","journal-title":"Eye"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939412006812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939412006812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:07:26Z","timestamp":1757596046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939412006812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0002939412006812"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2012.09.025","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the Revised American Academy of Ophthalmology Guidelines Regarding Hydroxychloroquine Screening on Actual Practice","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2012.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2012.10.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}